STAT

Opinion: A CDC veteran asks: Why is the agency ‘sitting on the sidelines’ in the fight against Covid-19?

After working 27 years at the CDC, I'm perplexed, and saddened, that the agency seems to be sitting on the sidelines for this #coronavirus pandemic.
In Monrovia, Liberia, virologist Heinrich Feldman handles blood samples while testing them for the Ebola virus in a lab the CDC opened in 2014. CDC staffers can't do that kind of work from home.

The public health challenge of our generation is right in front of us. SARS-CoV-2 appears to be the Andromeda strain that public health workers fear to see emerging. After many years of working at the Centers for Disease Control and Prevention, I’m perplexed, and saddened, that the agency seems to be sitting on the sidelines for this pandemic and is not building on the accumulated skills and experience from its past.

Nobody dismisses the worsening crisis or its ability to deal a potentially deadly blow to health systems and economies around the world. Health care providers throughout the U.S., emulating those in other countries, are improvising protective equipment. are the new N95 face masks. Clinicians

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About The Purdue Bankruptcy Ruling, A Merck Rejection, And More
In today's Pharmalittle roundup, we're reading about the Purdue bankruptcy ruling, a Merck rejection, and more.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About EMA Plans For GLP-1 Shortages, Walgreens Store Closings, And More
The European Medicines Agency and member countries announced several steps to address shortages of GLP-1 drugs.
STAT1 min read
STAT+: Don’t Write Off MDMA Yet: How The FDA Got On Board With Psychedelics
Psychedelic evangelists have been working to win over regulators since the 1980s, and those relationships helped persuade the FDA to sign off on research.

Related Books & Audiobooks